投稿咨询
Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini review, research articles and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism.
More specifically, in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; bioactivation, reactive metabolites, and developments for the identification of drug metabolites. Preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.
《Current Drug Metabolism》是一本由BENTHAM SCIENCE PUBL LTD出版商出版的专业医学期刊，该刊创刊于2000年，刊期Quarterly，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 4区，小类学科：生化与分子生物学 4区；药学 4区；在JCR（Journal Citation Reports）分区等级为Q3。该刊发文范围涵盖生化与分子生物学等领域，旨在及时、准确、全面地报道国内外生化与分子生物学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为3.408，平均审稿速度偏慢,4-8周。
| 大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
| 医学 | 4区 | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 PHARMACOLOGY & PHARMACY 药学 | 4区 4区 | 否 | 是 |
| JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
| Q3 | PHARMACOLOGY & PHARMACY | Q3 | 3.408 |
| BIOCHEMISTRY & MOLECULAR BIOLOGY | Q3 |
| 影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
| 3.408 | 97 | 0.00% | 55.79% | 未开放 | 偏慢,4-8周 |
课题、SCI/EI/SSCI怎么写？